Collegium Pharmaceutical, Inc.’s Post

The Collegium team is at the American Psychiatric Association Annual Meeting, one of the most important gatherings in psychiatry and a chance to engage in meaningful conversations with clinicians, researchers, and advocates who share our commitment to advancing patient care. We’re spotlighting our portfolio of differentiated medicines, each designed to address the complex, real-world needs of patients living with ADHD. If you're at APA, we'd love to connect. Come find us and let's talk. #APA2026